Xilio to Present New Immunotherapy Data at SITC Meeting
Xilio Therapeutics will unveil new clinical and preclinical data at the Society for Immunotherapy of Cancer’s annual meeting on...
eClinical Tech News
Achieve Life Sciences Grants New Hire Inducement Awards
Achieve Life Sciences has granted stock options covering 161,000 shares to five new employees under its 2024 equity inducement...
FDA Grants Breakthrough Status to Taysha’s Rett Gene Therapy
Taysha Gene Therapies has secured FDA Breakthrough Therapy designation for TSHA-102, an intrathecal AAV9 gene therapy for Rett syndrome,...
Kura, Kyowa Kirin Launch AML Trial for Dual Gene Mutations
Kura Oncology and Kyowa Kirin have dosed the first patient in a new cohort of the KOMET-007 study assessing...
Avalo Therapeutics Expands Leadership with Key Appointments
Avalo Therapeutics has expanded its leadership bench, appointing Taylor Boyd as chief business officer and Ashley Ivanowicz as senior...
e-therapeutics Relaunches as Tangram, Unveils LliBRA OS
Tangram Therapeutics, formerly e-therapeutics, has relaunched with a sharpened focus on RNA interference and unveiled LLIBRA OS, a next-generation...
Nanobiotix Updates Activities, H1 2025 Financial Results
Nanobiotix reported a step-change half year marked by clinical expansion with JNJ-1900 (NBTXR3), regulatory harmonization in Europe, and a...
Surging Hope: Rademikibart Data Presented at ERS Congress
Connect Biopharma presented new post-hoc analyses at ERS 2025 showing that rademikibart, its investigational anti–IL-4Rα antibody, delivered rapid and...
Novartis to Launch Direct-to-Patient Cosentyx Platform in US
Novartis will launch a US direct-to-patient platform on November 1, 2025, offering select units of Cosentyx at a 55%...
Cosmos Health Secures $300M for US Growth & AI Innovation
Cosmos Health has outlined a sweeping restructuring and growth plan anchored by an up to $300 million financing facility...